Last reviewed · How we verify
European Blood Pressure Intensive Control After Stroke - Pilot Trial (EPICS-Pilot)
Stroke is the third most common cause of death worldwide and the leading cause of disability. High blood pressure is an important risk factor for stroke. Lowering a person's blood pressure reduces the risk of future stroke or heart attack, and current guidelines recommend treatment to a target of \<130mmHg for secondary prevention. Home blood pressure measurement and telemonitoring are acceptable to patients, but there is uncertainty over the use of out of office blood pressure measurements in stroke patients in guidelines. This is a study designed to establish the feasibility of a larger clinical trial, comparing home blood pressure monitoring, telemonitoring and medication titration with standard care. The study hypothesis is that home BP measurement and telemonitoring with medication titration may lead to improved BP control compared to standard of care clinical practice.
Details
| Lead sponsor | University College Dublin |
|---|---|
| Phase | Phase 2 |
| Status | RECRUITING |
| Enrolment | 142 |
| Start date | 2024-05-02 |
| Completion | 2026-03 |
Conditions
- Ischemic Stroke
- Transient Ischemic Attack
Interventions
- anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration
- Standard of Care Blood Pressure Management with Antihypertensives
Primary outcomes
- Difference in mean SBP — 12 months (or last trial visit)
The difference in mean SBP between both groups, at 12 months (or last trial visit)
Countries
Ireland